Valuation: Ambee Pharmaceuticals Plc

Market Cap 181.56Cr 1.48Cr 1.27Cr 1.19Cr 1.09Cr 2.05Cr 140.89Cr 2.06Cr 14Cr 5.46Cr 71Cr 5.55Cr 5.43Cr 235.42Cr P/E 2024
189x
P/E 2025 369x
Enterprise Value 232.19Cr 1.89Cr 1.62Cr 1.52Cr 1.39Cr 2.62Cr 180.18Cr 2.64Cr 18Cr 6.98Cr 91Cr 7.09Cr 6.94Cr 301.07Cr EV / Sales 2024
10.4x
EV / Sales 2025 10.7x
Free-Float
22.75%
Yield 2024
0.13%
Yield 2025 0.12%
1 day-1.05%
1 week-2.81%
Current month-7.12%
1 month-6.37%
3 months-2.94%
6 months-2.93%
Current year+6.65%
1 week 750.3
Extreme 750.3
794.9
1 month 750.3
Extreme 750.3
830
Current year 689
Extreme 689
847
1 year 681
Extreme 681
895
3 years 633.4
Extreme 633.4
1,302.3
5 years 375.3
Extreme 375.3
1,302.3
10 years 353
Extreme 352.999999
1,302.3
Manager TitleAgeSince
Chief Executive Officer - -
Director of Finance/CFO - -
Chief Administrative Officer - -
Director TitleAgeSince
Chairman - -
Director/Board Member - -
Director/Board Member - -
Change 5-day change 1-year change 3-year change Capi.($)
-1.05%-2.81%-8.42%+17.47% 1.47Cr
-1.17%-0.03%+18.70%+70.05% 4.84TCr
+1.12%+1.41%+54.88%+122.68% 3.99TCr
-1.36%-1.36%-11.21%+14.14% 1.2TCr
+2.27%+4.12%+16.41%+81.30% 1.18TCr
+0.19%0.00%+30.98%+150.00% 918.66Cr
-0.45%+3.26%+24.53%+45.36% 787.42Cr
+1.30%+1.26%+54.43%-10.73% 725.43Cr
+1.60%+8.54%+25.00%+217.84% 710.43Cr
+0.95%-8.22%-39.88%+16.67% 526.33Cr
Average +0.34%+0.19%+16.54%+72.48% 1.49TCr
Weighted average by Cap. +0.15%+1.17%+26.83%+85.37%

Financials

2024 2025
Net sales 22Cr 17.84L 15.31L 14.37L 13.13L 24.78L 17Cr 24.9L 1.7Cr 65.92L 8.59Cr 66.99L 65.54L 28Cr 23Cr 18.76L 16.1L 15.11L 13.8L 26.05L 18Cr 26.17L 1.79Cr 69.3L 9.03Cr 70.43L 68.9L 30Cr
Net income 96.83L 78.79T 67.62T 63.47T 57.97T 1L 75.14L 1L 8L 3L 37.91L 3L 3L 1.26Cr 53.09L 43.2T 37.08T 34.8T 31.78T 59.98T 41.2L 60.27T 4L 2L 20.79L 2L 2L 68.84L
Net Debt 44Cr 36.18L 31.05L 29.14L 26.62L 50.24L 35Cr 50.48L 3.45Cr 1.34Cr 17Cr 1.36Cr 1.33Cr 58Cr 51Cr 41.19L 35.36L 33.18L 30.31L 57.2L 39Cr 57.48L 3.93Cr 1.52Cr 20Cr 1.55Cr 1.51Cr 66Cr
Logo Ambee Pharmaceuticals Plc
Ambee Pharmaceuticals Plc is a Bangladesh-based company. The business of the Company is to manufacture, buy, sell, export, or deal in all kinds of drugs, medicines, pharmaceuticals, chemicals, medical or any other preparations. It refines, manipulates or treats all such substances used in the pharmaceutical industry. The Company offers tablets, capsules, liquids, gel in tubes, and injectables. Its products include ANTAC, LAP, OM-20, OM-40, STOMACID, AMBEECLOX, AMBEEXIN, FLUXIN, MYCEF, MYCEF-DS, TRICEF, A-ROX, MYCIN, MYZID, HIFLOX, HIFLOX-XR, LEXLO, DOXILLIN, TETRAM, TACTIN, NALIDEX, AFLUZOLE, AFUVIN, KLION, AMETROL-VT, TRIBEN-DS, TRIBEN, SURAL, MESPA, NO-SPA, AMINOPHYLLINE, CODEX, DEXTROMETHORPHAN, NILKOF, ACES PLUS, AMBEECAL, AMBEECAL D, ACT, ACT PLUS, AROLAK, AROLAK-10, AROLAK30, HITFLAM, HITFLAM-SR, NAPROXIN, CINON, FUNGAKIL, AMASON, PREDNISOLONE, NOSTIS, ALUCTIN, NOCTIN, SEDUXEN, and PERO-L. The Company has approximately nine sales centers in all over Bangladesh.
Employees
474
Date Price Change Volume
25/26/25 BDT 755.10 -1.05% 713
24/26/24 BDT 763.10 -0.42% 254
23/26/23 BDT 766.30 -1.94% 1,640
20/26/20 BDT 781.50 -0.94% 586
19/26/19 BDT 788.90 +1.54% 102
  1. Stock Market
  2. Stocks
  3. AMBEEPHA Stock